Epstein Files Full PDF

CLICK HERE
Technopedia Center
PMB University Brochure
Faculty of Engineering and Computer Science
S1 Informatics S1 Information Systems S1 Information Technology S1 Computer Engineering S1 Electrical Engineering S1 Civil Engineering

faculty of Economics and Business
S1 Management S1 Accountancy

Faculty of Letters and Educational Sciences
S1 English literature S1 English language education S1 Mathematics education S1 Sports Education
teknopedia

  • Registerasi
  • Brosur UTI
  • Kip Scholarship Information
  • Performance
Flag Counter
  1. World Encyclopedia
  2. PHF20
PHF20
From Wikipedia, the free encyclopedia
Protein-coding gene in the species Homo sapiens
PHF20
Available structures
PDBOrtholog search: PDBe RCSB
List of PDB id codes

3P8D, 3Q1J, 3QII, 3SD4

Identifiers
AliasesPHF20, C20orf104, GLEA2, HCA58, NZF, TDRD20A, TZP, PHD finger protein 20
External IDsOMIM: 610335; MGI: 2444148; HomoloGene: 9507; GeneCards: PHF20; OMA:PHF20 - orthologs
Gene location (Human)
Chromosome 20 (human)
Chr.Chromosome 20 (human)[1]
Chromosome 20 (human)
Genomic location for PHF20
Genomic location for PHF20
Band20q11.22-q11.23Start35,771,974 bp[1]
End35,950,370 bp[1]
Gene location (Mouse)
Chromosome 2 (mouse)
Chr.Chromosome 2 (mouse)[2]
Chromosome 2 (mouse)
Genomic location for PHF20
Genomic location for PHF20
Band2|2 H1Start156,196,466 bp[2]
End156,309,952 bp[2]
RNA expression pattern
Bgee
HumanMouse (ortholog)
Top expressed in
  • endothelial cell

  • sperm

  • epithelium of colon

  • Achilles tendon

  • Brodmann area 23

  • germinal epithelium

  • amniotic fluid

  • glutes

  • visceral pleura

  • parietal pleura
Top expressed in
  • zygote

  • ectoderm

  • otic placode

  • otic vesicle

  • saccule

  • primary oocyte

  • secondary oocyte

  • Region I of hippocampus proper

  • cerebellar vermis

  • lobe of cerebellum
More reference expression data
BioGPS




More reference expression data
Gene ontology
Molecular function
  • histone acetyltransferase activity (H4-K8 specific)
  • DNA binding
  • histone acetyltransferase activity (H4-K5 specific)
  • metal ion binding
  • histone acetyltransferase activity (H4-K16 specific)
  • protein binding
  • nucleic acid binding
  • DNA-binding transcription factor activity, RNA polymerase II-specific
Cellular component
  • nuclear membrane
  • histone acetyltransferase complex
  • nucleus
  • nucleoplasm
  • cytosol
  • MLL1 complex
Biological process
  • histone H4-K16 acetylation
  • regulation of transcription, DNA-templated
  • transcription, DNA-templated
  • histone H4-K5 acetylation
  • histone H4-K8 acetylation
  • regulation of signal transduction by p53 class mediator
  • chromatin organization
  • regulation of transcription by RNA polymerase II
Sources:Amigo / QuickGO
Orthologs
SpeciesHumanMouse
Entrez

51230

228829

Ensembl

ENSG00000025293

ENSMUSG00000038116

UniProt

Q9BVI0
Q5JWZ0

Q8BLG0

RefSeq (mRNA)

NM_016436

NM_172674

RefSeq (protein)

NP_057520

NP_766262

Location (UCSC)Chr 20: 35.77 – 35.95 MbChr 2: 156.2 – 156.31 Mb
PubMed search[3][4]
Wikidata
View/Edit HumanView/Edit Mouse

PHD finger protein 20 is a protein that in humans is encoded by the PHF20 gene.[5]

References

[edit]
  1. ^ a b c GRCh38: Ensembl release 89: ENSG00000025293 – Ensembl, May 2017
  2. ^ a b c GRCm38: Ensembl release 89: ENSMUSG00000038116 – Ensembl, May 2017
  3. ^ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  4. ^ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  5. ^ "Entrez Gene: PHF20 PHD finger protein 20".

Further reading

[edit]
  • Fischer U, Struss AK, Hemmer D, Pallasch CP, Steudel WI, Meese E (November 2001). "Glioma-expressed antigen 2 (GLEA2): a novel protein that can elicit immune responses in glioblastoma patients and some controls". Clin. Exp. Immunol. 126 (2): 206–13. doi:10.1046/j.1365-2249.2001.01635.x. PMC 1906187. PMID 11703362.
  • Behrends U, Schneider I, Rössler S, Frauenknecht H, Golbeck A, Lechner B, Eigenstetter G, Zobywalski C, Müller-Weihrich S, Graubner U, Schmid I, Sackerer D, Späth M, Goetz C, Prantl F, Asmuss HP, Bise K, Mautner J (August 2003). "Novel tumor antigens identified by autologous antibody screening of childhood medulloblastoma cDNA libraries". Int. J. Cancer. 106 (2): 244–51. doi:10.1002/ijc.11208. PMID 12800201. S2CID 36836051.
  • Pallasch CP, Struss AK, Munnia A, König J, Steudel WI, Fischer U, Meese E (November 2005). "Autoantibodies against GLEA2 and PHF3 in glioblastoma: tumor-associated autoantibodies correlated with prolonged survival". Int. J. Cancer. 117 (3): 456–9. doi:10.1002/ijc.20929. PMID 15906353. S2CID 32083805.
  • Cui G, Park S, Badeaux AI, Kim D, Lee J, Thompson JR, Yan F, Kaneko S, Yuan Z, Botuyan MV, Bedford MT, Cheng JQ, Mer G (August 2012). "PHF20 is an effector protein of p53 double lysine methylation that stabilizes and activates p53". Nat. Struct. Mol. Biol. 19 (9): 916–24. doi:10.1038/nsmb.2353. PMC 3454513. PMID 22864287.

External links

[edit]
  • PHF20+protein,+human at the U.S. National Library of Medicine Medical Subject Headings (MeSH)

This article incorporates text from the United States National Library of Medicine, which is in the public domain.

  • v
  • t
  • e
Transcription factors and intracellular receptors
(1) Basic domains
(1.1) Basic leucine zipper (bZIP)
  • Activating transcription factor
    • AATF
    • 1
    • 2
    • 3
    • 4
    • 5
    • 6
    • 7
  • AP-1
    • c-Fos
    • FOSB
    • FOSL1
    • FOSL2
    • JDP2
    • c-Jun
    • JUNB
    • JunD
  • BACH
    • 1
    • 2
  • BATF
  • BLZF1
  • C/EBP
    • α
    • β
    • γ
    • δ
    • ε
    • ζ
  • CREB
    • 1
    • 3
    • L1
  • CREM
  • DBP
  • DDIT3
  • GABPA
  • GCN4
  • HLF
  • MAF
    • B
    • sMaf
      • F
      • G
      • K
  • NFE
    • 2
    • L1
    • L2
    • L3
  • NFIL3
  • NRL
  • NRF
    • 1
    • 2
    • 3
  • XBP1
(1.2) Basic helix-loop-helix (bHLH)
Group A
  • AS-C
    • ASCL1
    • ASCL2
  • ATOH1
  • HAND
    • 1
    • 2
  • MESP2
  • Myogenic regulatory factors
    • MyoD
    • Myogenin
    • MYF5
    • MYF6
  • NeuroD
    • 1
    • 2
  • Neurogenins
    • 1
    • 2
    • 3
  • OLIG
    • 1
    • 2
  • Paraxis
    • TCF15
    • Scleraxis
  • SLC
    • LYL1
    • TAL
      • 1
      • 2
  • Twist
Group B
  • FIGLA
  • Myc
    • c-Myc
    • l-Myc
    • n-Myc
  • MXD4
  • TCF4
Group C
bHLH-PAS
  • AhR
  • AHRR
  • ARNT
    • ARNTL
    • ARNTL2
  • CLOCK
  • HIF
    • 1A
    • EPAS1
    • 3A
  • NPAS
    • 1
    • 2
    • 3
  • PER
    • 1
    • 2
    • 3
    • Period
  • SIM
    • 1
    • 2
Group D
  • DEC
    • 1
    • 2
  • BHLHA9
  • Pho4
  • ID
    • 1
    • 2
    • 3
    • 4
Group E
  • HES
    • 1
    • 2
    • 3
    • 4
    • 5
    • 6
    • 7
  • HEY
    • 1
    • 2
    • L
Group F
bHLH-COE
  • EBF1
(1.3) bHLH-ZIP
  • AP-4
  • MAX
    • MXD1
    • MXD3
  • MITF
  • MNT
  • MLX
  • MLXIPL
  • MXI1
  • Myc
  • SREBP
    • 1
    • 2
  • USF1
(1.4) NF-1
  • NFI
    • A
    • B
    • C
    • X
  • SMAD
    • R-SMAD
      • 1
      • 2
      • 3
      • 5
      • 9
    • I-SMAD
      • 6
      • 7
    • 4)
(1.5) RF-X
  • RFX
    • 1
    • 2
    • 3
    • 4
    • 5
    • 6
    • ANK
(1.6) Basic helix-span-helix (bHSH)
  • AP-2
    • α
    • β
    • γ
    • δ
    • ε
(2) Zinc finger DNA-binding domains
(2.1) Nuclear receptor (Cys4)
subfamily 1
  • Thyroid hormone
    • α
    • β
  • CAR
  • FXR
  • LXR
    • α
    • β
  • PPAR
    • α
    • β/δ
    • γ
  • PXR
  • RAR
    • α
    • β
    • γ
  • ROR
    • α
    • β
    • γ
  • Rev-ErbA
    • α
    • β
  • VDR
subfamily 2
  • COUP-TF
    • (I
    • II
  • Ear-2
  • HNF4
    • α
    • γ
  • PNR
  • RXR
    • α
    • β
    • γ
  • Testicular receptor
    • 2
    • 4
  • TLX
subfamily 3
  • Steroid hormone
    • Androgen
    • Estrogen
      • α
      • β
    • Glucocorticoid
    • Mineralocorticoid
    • Progesterone
  • Estrogen related
    • α
    • β
    • γ
subfamily 4
  • NUR
    • NGFIB
    • NOR1
    • NURR1
subfamily 5
  • LRH-1
  • SF1
subfamily 6
  • GCNF
subfamily 0
  • DAX1
  • SHP
(2.2) Other Cys4
  • GATA
    • 1
    • 2
    • 3
    • 4
    • 5
    • 6
  • MTA
    • 1
    • 2
    • 3
  • TRPS1
(2.3) Cys2His2
  • General transcription factors
    • TFIIA
    • TFIIB
    • TFIID
    • TFIIE
      • 1
      • 2
    • TFIIF
    • 1
    • 2
      • TFIIH
      • 1
      • 2
      • 4
      • 2I
      • 3A
      • 3C1
      • 3C2
  • ATBF1
  • BCL
    • 6
    • 11A
    • 11B
  • CTCF
  • E4F1
  • EGR
    • 1
    • 2
    • 3
    • 4
  • ERV3
  • GFI1
  • GLI family
    • 1
    • 2
    • 3
    • REST
    • S1
    • S2
    • YY1
  • HIC
    • 1
    • 2
  • HIVEP
    • 1
    • 2
    • 3
  • IKZF
    • 1
    • 2
    • 3
  • ILF
    • 2
    • 3
  • Sp/KLF family
    • KLF
      • 1
      • 2
      • 3
      • 4
      • 5
      • 6
      • 7
      • 8
      • 9
      • 10
      • 11
      • 12
      • 13
      • 14
      • 15
      • 17
    • SP
      • 1
      • 2
      • 4
      • 7
      • 8
  • MTF1
  • MYT1
  • OSR1
  • PRDM9
  • SALL
    • 1
    • 2
    • 3
    • 4
  • TSHZ3
  • WT1
  • Zbtb7
    • 7A
    • 7B
  • ZBTB
    • 11
    • 16
    • 17
    • 20
    • 21
    • 32
    • 33
    • 40
  • zinc finger
    • 3
    • 7
    • 9
    • 10
    • 19
    • 22
    • 24
    • 33B
    • 34
    • 35
    • 41
    • 43
    • 44
    • 51
    • 74
    • 143
    • 146
    • 148
    • 165
    • 202
    • 217
    • 219
    • 238
    • 239
    • 259
    • 267
    • 268
    • 281
    • 300
    • 318
    • 330
    • 346
    • 350
    • 365
    • 366
    • 384
    • 423
    • 451
    • 452
    • 471
    • 593
    • 638
    • 644
    • 649
    • 655
    • 804A
(2.4) Cys6
  • HIVEP1
(2.5) Alternating composition
  • AIRE
  • DIDO1
  • GRLF1
  • ING
    • 1
    • 2
    • 4
  • JARID
    • 1A
    • 1B
    • 1C
    • 1D
    • 2
  • JMJD1B
(2.6) WRKY
  • WRKY
(3) Helix-turn-helix domains
(3.1) Homeodomain
Antennapedia
ANTP class
protoHOX
Hox-like
  • ParaHox
    • Gsx
      • 1
      • 2
    • Xlox
      • PDX1
    • Cdx
      • 1
      • 2
      • 4
  • extended Hox: Evx1
  • Evx2
  • MEOX1
  • MEOX2
  • Homeobox
    • A1
    • A2
    • A3
    • A4
    • A5
    • A7
    • A9
    • A10
    • A11
    • A13
    • B1
    • B2
    • B3
    • B4
    • B5
    • B6
    • B7
    • B8
    • B9
    • B13
    • C4
    • C5
    • C6
    • C8
    • C9
    • C10
    • C11
    • C12
    • C13
    • D1
    • D3
    • D4
    • D8
    • D9
    • D10
    • D11
    • D12
    • D13
  • GBX1
  • GBX2
  • MNX1
metaHOX
NK-like
  • BARHL1
  • BARHL2
  • BARX1
  • BARX2
  • BSX
  • DBX
    • 1
    • 2
  • DLX
    • 1
    • 2
    • 3
    • 4
    • 5
    • 6
  • EMX
    • 1
    • 2
  • EN
    • 1
    • 2
  • HHEX
  • HLX
  • LBX1
  • LBX2
  • MSX
    • 1
    • 2
  • NANOG
  • NKX
    • 2-1
    • 2-2
    • 2-3
    • 2-5
    • 3-1
    • 3-2
    • HMX1
    • HMX2
    • HMX3
    • 6-1
    • 6-2
  • NOTO
  • TLX1
  • TLX2
  • TLX3
  • VAX1
  • VAX2
other
  • ARX
  • CRX
  • CUTL1
  • FHL
    • 1
    • 2
    • 3
  • HESX1
  • HOPX
  • LMX
    • 1A
    • 1B
  • NOBOX
  • TALE
    • IRX
      • 1
      • 2
      • 3
      • 4
      • 5
      • 6
      • MKX
    • MEIS
      • 1
      • 2
    • PBX
      • 1
      • 2
      • 3
    • PKNOX
      • 1
      • 2
    • SIX
      • 1
      • 2
      • 3
      • 4
      • 5
  • PHF
    • 1
    • 3
    • 6
    • 8
    • 10
    • 16
    • 17
    • 20
    • 21A
  • POU domain
    • PIT-1
    • BRN-3: A
    • B
    • C
    • Octamer transcription factor: 1
    • 2
    • 3/4
    • 6
    • 7
    • 11
  • SATB2
  • ZEB
    • 1
    • 2
(3.2) Paired box
  • PAX
    • 1
    • 2
    • 3
    • 4
    • 5
    • 6
    • 7
    • 8
    • 9
  • PRRX
    • 1
    • 2
  • PROP1
  • PHOX
    • 2A
    • 2B
  • RAX
  • SHOX
  • SHOX2
  • VSX1
  • VSX2
  • Bicoid
    • GSC
    • BICD2
    • OTX
      • 1
      • 2
    • PITX
      • 1
      • 2
      • 3
(3.3) Fork head / winged helix
  • E2F
    • 1
    • 2
    • 3
    • 4
    • 5
  • FOX proteins
    • A1
    • A2
    • A3
    • B1
    • B2
    • C1
    • C2
    • D1
    • D2
    • D3
    • D4
    • D4L1
    • D4L3
    • D4L4
    • D4L5
    • D4L6
    • E1
    • E3
    • F1
    • F2
    • G1
    • H1
    • I1
    • I2
    • I3
    • J1
    • J2
    • J3
    • K1
    • K2
    • L1
    • L2
    • M1
    • N1
    • N2
    • N3
    • N4
    • O1
    • O3
    • O4
    • O6
    • P1
    • P2
    • P3
    • P4
    • Q1
    • R1
    • R2
    • S1
(3.4) Heat shock factors
  • HSF
    • 1
    • 2
    • 4
(3.5) Tryptophan clusters
  • ELF
    • 2
    • 4
    • 5
  • EHF
  • ELK
    • 1
    • 3
    • 4
  • ERF
  • ETS
    • 1
    • 2
    • ERG
    • SPIB
  • ETV
    • 1
    • 4
    • 5
    • 6
  • FLI1
  • Interferon regulatory factors
    • 1
    • 2
    • 3
    • 4
    • 5
    • 6
    • 7
    • 8
  • MYB
  • MYBL2
(3.6) TEA domain
  • transcriptional enhancer factor
    • 1
    • 2
    • 3
    • 4
(4) β-Scaffold factors with minor groove contacts
(4.1) Rel homology region
  • NF-κB
    • NFKB1
    • NFKB2
    • REL
    • RELA
    • RELB
  • NFAT
    • C1
    • C2
    • C3
    • C4
    • 5
(4.2) STAT
  • STAT
    • 1
    • 2
    • 3
    • 4
    • 5
    • 6
(4.3) p53-like
  • p53 p63 p73 family
    • p53
    • TP63
    • p73
  • TBX
    • 1
    • 2
    • 3
    • 5
    • 19
    • 21
    • 22
    • TBR1
    • TBR2
    • TFT
  • MYRF
(4.4) MADS box
  • Mef2
    • A
    • B
    • C
    • D
  • SRF
(4.6) TATA-binding proteins
  • TBP
  • TBPL1
(4.7) High-mobility group
  • BBX
  • HMGB
    • 1
    • 2
    • 3
    • 4
  • HMGN
    • 1
    • 2
    • 3
    • 4
  • HNF
    • 1A
    • 1B
  • SOX
    • 1
    • 2
    • 3
    • 4
    • 5
    • 6
    • 8
    • 9
    • 10
    • 11
    • 12
    • 13
    • 14
    • 15
    • 17
    • 18
    • 21
  • SRY
  • SSRP1
  • TCF/LEF
    • TCF
      • 1
      • 3
      • 4
    • LEF1
  • TOX
    • 1
    • 2
    • 3
    • 4
(4.9) Grainyhead
  • TFCP2
(4.10) Cold-shock domain
  • CSDA
  • YBX1
(4.11) Runt
  • CBF
    • CBFA2T2
    • CBFA2T3
    • RUNX1
    • RUNX2
    • RUNX3
    • RUNX1T1
(0) Other transcription factors
(0.2) HMGI(Y)
  • HMGA
    • 1
    • 2
  • HBP1
(0.3) Pocket domain
  • Rb
  • RBL1
  • RBL2
(0.5) AP-2/EREBP-related factors
  • Apetala 2
  • EREBP
  • B3
(0.6) Miscellaneous
  • ARID
    • 1A
    • 1B
    • 2
    • 3A
    • 3B
    • 4A
  • CAP
  • IFI
    • 16
    • 35
  • MLL
    • 2
    • 3
    • T1
  • MNDA
  • NFY
    • A
    • B
    • C
  • Rho/Sigma
see also transcription factor/coregulator deficiencies


Stub icon

This article on a gene on human chromosome 20 is a stub. You can help Wikipedia by adding missing information.

  • v
  • t
  • e
Retrieved from "https://en.wikipedia.org/w/index.php?title=PHF20&oldid=1301023080"
Categories:
  • Genes on human chromosome 20
  • Transcription factors
  • Human chromosome 20 gene stubs
Hidden categories:
  • Articles with short description
  • Short description matches Wikidata
  • Wikipedia articles incorporating text from the United States National Library of Medicine
  • All stub articles

  • indonesia
  • Polski
  • العربية
  • Deutsch
  • English
  • Español
  • Français
  • Italiano
  • مصرى
  • Nederlands
  • 日本語
  • Português
  • Sinugboanong Binisaya
  • Svenska
  • Українська
  • Tiếng Việt
  • Winaray
  • 中文
  • Русский
Sunting pranala
url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url
Pusat Layanan

UNIVERSITAS TEKNOKRAT INDONESIA | ASEAN's Best Private University
Jl. ZA. Pagar Alam No.9 -11, Labuhan Ratu, Kec. Kedaton, Kota Bandar Lampung, Lampung 35132
Phone: (0721) 702022
Email: pmb@teknokrat.ac.id